GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZXF) » Definitions » Beneish M-Score

SDZXF (Sandoz Group AG) Beneish M-Score : -2.61 (As of Mar. 24, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.61 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Sandoz Group AG's Beneish M-Score or its related term are showing as below:

SDZXF' s Beneish M-Score Range Over the Past 10 Years
Min: -2.61   Med: -2.61   Max: -2.61
Current: -2.61

During the past 3 years, the highest Beneish M-Score of Sandoz Group AG was -2.61. The lowest was -2.61. And the median was -2.61.


Sandoz Group AG Beneish M-Score Historical Data

The historical data trend for Sandoz Group AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Beneish M-Score Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24
Beneish M-Score
- - -2.61

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24
Beneish M-Score - - - - -2.61

Competitive Comparison of Sandoz Group AG's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sandoz Group AG's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's Beneish M-Score falls into.



Sandoz Group AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Sandoz Group AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9971+0.528 * 0.9641+0.404 * 0.9868+0.892 * 1.0406+0.115 * 1.0965
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9787+4.679 * -0.032953-0.327 * 1.0788
=-2.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was $3,146 Mil.
Revenue was $10,384 Mil.
Gross Profit was $4,926 Mil.
Total Current Assets was $7,801 Mil.
Total Assets was $19,907 Mil.
Property, Plant and Equipment(Net PPE) was $1,988 Mil.
Depreciation, Depletion and Amortization(DDA) was $502 Mil.
Selling, General, & Admin. Expense(SGA) was $2,433 Mil.
Total Current Liabilities was $6,307 Mil.
Long-Term Debt & Capital Lease Obligation was $4,666 Mil.
Net Income was $0 Mil.
Gross Profit was $0 Mil.
Cash Flow from Operations was $656 Mil.
Total Receivables was $3,032 Mil.
Revenue was $9,979 Mil.
Gross Profit was $4,564 Mil.
Total Current Assets was $7,572 Mil.
Total Assets was $19,430 Mil.
Property, Plant and Equipment(Net PPE) was $1,850 Mil.
Depreciation, Depletion and Amortization(DDA) was $525 Mil.
Selling, General, & Admin. Expense(SGA) was $2,389 Mil.
Total Current Liabilities was $5,698 Mil.
Long-Term Debt & Capital Lease Obligation was $4,230 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3146 / 10384) / (3032 / 9979)
=0.302966 / 0.303838
=0.9971

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4564 / 9979) / (4926 / 10384)
=0.45736 / 0.474384
=0.9641

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (7801 + 1988) / 19907) / (1 - (7572 + 1850) / 19430)
=0.508263 / 0.51508
=0.9868

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=10384 / 9979
=1.0406

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(525 / (525 + 1850)) / (502 / (502 + 1988))
=0.221053 / 0.201606
=1.0965

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2433 / 10384) / (2389 / 9979)
=0.234303 / 0.239403
=0.9787

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4666 + 6307) / 19907) / ((4230 + 5698) / 19430)
=0.551213 / 0.510962
=1.0788

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(0 - 0 - 656) / 19907
=-0.032953

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Sandoz Group AG has a M-score of -2.64 suggests that the company is unlikely to be a manipulator.


Sandoz Group AG Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sandoz Group AG Business Description

Address
Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as the first US biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in its pipeline.